Discontinuation report STREPTOMYCIN FOR INJECTION USP
| Report ID | 209235 |
| Drug Identification Number | 02243660 |
| Brand name | STREPTOMYCIN FOR INJECTION USP |
| Common or Proper name | STREPTOMYCIN FOR INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | STREPTOMYCIN |
| Strength(s) | 1G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1 VIAL |
| ATC code | J01GA |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2024-08-31 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Product remains available and we anticipate this inventory to last 9-10 months based on current demand with an expiry of April 30, 2026. |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2023-11-06 | French | Compare |
| v1 | 2023-11-06 | English | Compare |
Showing 1 to 2 of 2